Track Prenetics Global Limited Warrant — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Prenetics Global Limited Warrant PRENW · Stock Open Prenetics Global Limited Warrant in new tab

0.0100 USD
EPS
-11.04
P/B
0.00
ROE
-40.77
Beta
0.25
Loading chart...
Key Metrics
Earnings dateNov. 5, 2026
EPS-11.04
Book Value7.13
Price to Book0.00
Debt/Equity0.38
Growth
Revenue Growth1.08%

DCF valuation

Model fair value for Prenetics Global Limited Warrant (PRENW)
Result
Sign in to run the valuation for PRENW.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Prenetics Global Limited Warrant Logo Prenetics Global Limited Warrant Analysis (PRENW)

Hong Kong Health Care Official Website Stock

Is Prenetics Global Limited Warrant a good investment? Prenetics Global Limited Warrant (PRENW) is currently trading at 0.0100 USD.

Earnings Schedule: Prenetics Global Limited Warrant is expected to release its next earnings report on Nov. 5, 2026.

Investor FAQ

Does Prenetics Global Limited Warrant pay a dividend?

No, it does not currently pay a dividend.

What asset class is Prenetics Global Limited Warrant?

Prenetics Global Limited Warrant is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of -11.04.

Company Profile

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Exchange Ticker
NMS (United States) PRENW
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion